STOCK TITAN

Elanco Animal Health (NYSE: ELAN) grants CEO deferred stock units

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc reported that President, CEO and Director Jeffrey N. Simmons received a grant of 113.4857 deferred stock units on 2026-07-24 at $24.9100 per unit, increasing his direct deferred stock unit holdings to 24,884.3878 units. Each unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares after termination of employment or in a specified future year under the company’s Executive Deferral and Stock Match Plan.

Positive

  • None.

Negative

  • None.
Insider Simmons Jeffrey N
Role PRESIDENT, CEO AND DIRECTOR
Type Security Shares Price Value
Grant/Award Deferred Stock Units F1, F2 113.4857 $24.91 $3K
Holdings After Transaction: Deferred Stock Units — 24,884.3878 shares (Direct)
Footnotes (2)
  1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Deferred stock units granted 113.4857 units Grant to Jeffrey N. Simmons on 2026-07-24
Grant price per deferred stock unit $24.9100 per unit Valuation used for the 2026-07-24 award
Deferred stock units held after grant 24884.3878 units Total direct deferred stock unit holdings of Jeffrey N. Simmons after the transaction
Underlying common shares per unit 1 share per unit Each deferred stock unit represents the right to receive one share or cash equivalent
Deferred Stock Units financial
"Each deferred stock unit represents the right to receive one share of Company common stock"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
cash equivalent financial
"the right to receive one share of Company common stock or the cash equivalent"
Executive Deferral and Stock Match Plan financial
"in accordance with Executive Deferral and Stock Match Plan."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Elanco (ELAN) report for Jeffrey N. Simmons?

Elanco reported that Jeffrey N. Simmons, its President, CEO and Director, received a grant of 113.4857 deferred stock units on 2026-07-24 at $24.9100 per unit, increasing his total deferred stock unit holdings to 24,884.3878 units.

What are the deferred stock units granted to Elanco (ELAN) CEO Jeffrey N. Simmons?

The grant consists of deferred stock units, each representing the right to receive one share of Elanco common stock or the cash equivalent. These units are a form of long-term compensation tied to the company’s equity value rather than immediate cash payment.

When will the deferred stock units granted at Elanco (ELAN) to the CEO settle?

The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, in line with the terms of the Executive Deferral and Stock Match Plan described in the disclosure.

How many deferred stock units does Elanco (ELAN) CEO hold after this grant?

Following the reported grant, Jeffrey N. Simmons holds 24,884.3878 deferred stock units directly. This figure reflects his updated position after acquiring 113.4857 units in the latest award, as disclosed in the ownership table for the derivative securities.

Does the Elanco (ELAN) deferred stock unit grant to the CEO involve underlying common stock?

Yes. Each deferred stock unit corresponds to one share of Elanco common stock as the underlying security. At settlement, the company may deliver shares or the cash equivalent, consistent with the plan’s terms governing these equity-linked compensation awards.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Simmons Jeffrey N

(Last)(First)(Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
450 ELANCO CIRCLE

(Street)
INDIANAPOLIS INDIANA 46221

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
PRESIDENT, CEO AND DIRECTOR
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)07/24/2026A113.4857 (2) (2)Common Stock113.4857$24.9124,884.3878D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons07/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)